BioScrip (BIOS) Posts Q2 GAAP Loss of $3.60/Share; Will Review Strategic Alternatives

Go back to BioScrip (BIOS) Posts Q2 GAAP Loss of $3.60/Share; Will Review Strategic Alternatives

SunTrust Downgrades BioScrip (BIOS) to Neutral

August 11, 2015 7:15 AM EDT

SunTrust Robinson Humphrey downgraded BioScrip (NASDAQ: BIOS) from Buy to Neutral with a price target of $2.00 (from $5.00).

For an analyst ratings summary and ratings history on BioScrip click here. For more ratings news on BioScrip click here.

Shares of BioScrip closed at $2.08 yesterday.

... More